ncRNA name
hsa-miR-30
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
LC3-II
Cancer name
Gastric Cancer
Cancer site
Stomach
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Down
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
MiR-30 decreases multidrug resistance in human gastric cancer cells by modulating cell autophagy.
Tissue resource
human gastric cancer cell lines SGC-7901
Experiment
qRT-PCR,Western blot
Institute
the Cell Bank of the Chinese Academy of Medical Sciences
Country
China
Continent
Asia